Education
About Us
Working with TipRanks
Follow Us
medmix AG (CH:MEDX)
:MEDX
MEDX Stock Chart & Stats
CHF10.62
CHF0.32(2.96%)
At close: 4:00 PM EST
CHF10.62
CHF0.32(2.96%)
Day’s Range― - ―
52-Week RangeCHF8.10 - CHF13.72
Previous CloseN/A
Volume22.50K
Average Volume (3M)115.75K
Market Cap
CHF439.86M
Enterprise ValueCHF732.00M
Total Cash (Recent Filing)CHF108.40M
Total Debt (Recent Filing)CHF320.50M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Feb 26, 2026EPS Estimate
0.33Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)0.39
Shares Outstanding41,262,370
10 Day Avg. Volume183,978
30 Day Avg. Volume115,752
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.74
P/FCF Ratio9.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.72
Revenue Forecast (FY)CHF452.40M
medmix AG News
MEDX FAQ
What was medmix AG’s price range in the past 12 months?
medmix AG lowest stock price was CHF8.10 and its highest was CHF13.72 in the past 12 months.
What is medmix AG’s market cap?
medmix AG’s market cap is CHF439.86M.
When is medmix AG’s upcoming earnings report date?
medmix AG’s upcoming earnings report date is Feb 26, 2026 which is in 70 days.
How were medmix AG’s earnings last quarter?
medmix AG released its earnings results on Jul 23, 2025. The company reported CHF0.39 earnings per share for the quarter, missing the consensus estimate of CHF0.4 by -CHF0.01.
Is medmix AG overvalued?
According to Wall Street analysts medmix AG’s price is currently Overvalued.
Does medmix AG pay dividends?
medmix AG pays a Annually dividend of CHF0.5 which represents an annual dividend yield of 4.69%. See more information on medmix AG dividends here
What is medmix AG’s EPS estimate?
medmix AG’s EPS estimate is 0.33.
How many shares outstanding does medmix AG have?
medmix AG has 41,262,370 shares outstanding.
What happened to medmix AG’s price movement after its last earnings report?
medmix AG reported an EPS of CHF0.39 in its last earnings report, missing expectations of CHF0.4. Following the earnings report the stock price went down -5.419%.
Which hedge fund is a major shareholder of medmix AG?
Currently, no hedge funds are holding shares in CH:MEDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
medmix AG
medmix AG (MEDX) is a global leader in the development and manufacturing of advanced delivery systems and solutions for the healthcare and consumer markets. The company specializes in producing innovative products such as injection systems, medical devices, and consumer goods that enhance the delivery of pharmaceuticals, vaccines, and other healthcare solutions. With a focus on precision engineering and sustainable practices, medmix operates across several sectors, including healthcare, pharmaceuticals, and consumer products, serving a diverse range of clients worldwide.
Technical Analysis
Rieter Holding AG
―
Komax Holding AG
―
Feintool International Holding AG
―
Mikron Holding AG
―
StarragTornos Group AG
―
Options Prices
Currently, No data available
---